Fight The New Drug Inc
EIN: 263550143 · Murray, UT · NTEE: F50
| Metric | Value |
|---|---|
| Total Revenue | $895K |
| Total Expenses | $1.2M |
| Net Assets | $294K |
Is Fight The New Drug Inc Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Fight The New Drug Inc
Fight The New Drug Inc (EIN: 263550143) is a nonprofit organization based in Murray, UT, classified under NTEE code F50. The organization reported total revenue of $895K and total assets of $143K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Fight The New Drug Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Fight The New Drug Inc is a small nonprofit that has been operating for 17 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 8.7%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $698K |
| Total Expenses | $1.2M |
| Surplus / Deficit | $-529,291 |
| Total Assets | $357K |
| Total Liabilities | $63K |
| Net Assets | $294K |
| Operating Margin | -75.8% |
| Debt-to-Asset Ratio | 17.7% |
| Months of Reserves | 3.5 months |
Financial Health Grade: B
In 2023, Fight The New Drug Inc reported a deficit of $529K with expenses exceeding revenue, holds 3.5 months of operating reserves (adequate), has a debt-to-asset ratio of 17.7% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Fight The New Drug Inc's revenue has grown at a compound annual growth rate (CAGR) of 8.7%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -51.5% | -20.8% | -56.9% |
| 2022 | -5.2% | -1.5% | -5.7% |
| 2021 | -5.9% | +1.5% | -7.2% |
| 2020 | +293.1% | -4.8% | +9.2% |
| 2019 | -72.0% | +7.2% | -58.7% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2009 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Fight The New Drug Inc has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Fight The New Drug Inc with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $529K, with expenses exceeding revenue.
- Debt-to-asset ratio: 17.7%.
Frequently Asked Questions about Fight The New Drug Inc
Is Fight The New Drug Inc a legitimate charity?
Fight The New Drug Inc (EIN: 263550143) is a registered tax-exempt nonprofit based in Utah. It has 13 years of IRS 990 filings on record. Total revenue: $895K. No red flags identified. Financial health grade: B.
How does Fight The New Drug Inc spend its money?
Fight The New Drug Inc reported $895K in total revenue in IRS 990 filings. 13 years of filing data available. Expenses exceeded revenue in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Fight The New Drug Inc tax-deductible?
Fight The New Drug Inc is registered as a tax-exempt nonprofit (EIN: 263550143). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Fight The New Drug Inc located?
Fight The New Drug Inc is headquartered in Murray, Utah and files with the IRS under EIN 263550143. It is classified under NTEE code F50.
How many years of IRS 990 filings does Fight The New Drug Inc have?
Fight The New Drug Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $895K in total revenue.
Filing History
IRS 990 filing history for Fight The New Drug Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Fight The New Drug Inc's revenue has grown by 173.2%, moving from $255K to $698K. Total assets increased by 722.8% over the same period, from $43K to $357K. Total functional expenses rose by 381.4%, from $255K to $1.2M. In its most recent filing year (2023), Fight The New Drug Inc reported a deficit of $529K, with expenses exceeding revenue. The organization holds $63K in liabilities against $357K in assets (debt-to-asset ratio: 17.7%), resulting in net assets of $294K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $698K | $1.2M | $357K | $63K | — | View 990 |
| 2022 | $1.4M | $1.5M | $828K | $121K | — | View 990 |
| 2021 | $1.5M | $1.6M | $878K | $61K | — | View 990 |
| 2020 | $1.6M | $1.5M | $947K | $75K | — | View 990 |
| 2019 | $410K | $1.6M | $867K | $58K | — | View 990 |
| 2018 | $1.5M | $1.5M | $2.1M | $72K | — | View 990 |
| 2017 | $3.0M | $1.6M | $2.1M | $47K | — | View 990 |
| 2016 | $1.5M | $1.8M | $710K | $19K | — | View 990 |
| 2015 | $1.7M | $1.3M | $1.0M | $26K | — | View 990 |
| 2014 | $1.1M | $750K | $546K | $11K | — | View 990 |
| 2013 | $687K | $590K | $189K | $1K | — | View 990 |
| 2012 | $406K | $357K | $92K | $4K | — | View 990 |
| 2011 | $255K | $255K | $43K | $5K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $698K, expenses of $1.2M, and assets of $357K (revenue -51.5% year-over-year).
- 2022: Revenue of $1.4M, expenses of $1.5M, and assets of $828K (revenue -5.2% year-over-year).
- 2021: Revenue of $1.5M, expenses of $1.6M, and assets of $878K (revenue -5.9% year-over-year).
- 2020: Revenue of $1.6M, expenses of $1.5M, and assets of $947K (revenue +293.1% year-over-year).
- 2019: Revenue of $410K, expenses of $1.6M, and assets of $867K (revenue -72.0% year-over-year).
- 2018: Revenue of $1.5M, expenses of $1.5M, and assets of $2.1M (revenue -50.5% year-over-year).
- 2017: Revenue of $3.0M, expenses of $1.6M, and assets of $2.1M (revenue +98.3% year-over-year).
- 2016: Revenue of $1.5M, expenses of $1.8M, and assets of $710K (revenue -14.6% year-over-year).
- 2015: Revenue of $1.7M, expenses of $1.3M, and assets of $1.0M (revenue +64.2% year-over-year).
- 2014: Revenue of $1.1M, expenses of $750K, and assets of $546K (revenue +54.8% year-over-year).
- 2013: Revenue of $687K, expenses of $590K, and assets of $189K (revenue +69.1% year-over-year).
- 2012: Revenue of $406K, expenses of $357K, and assets of $92K (revenue +59.1% year-over-year).
- 2011: Revenue of $255K, expenses of $255K, and assets of $43K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Fight The New Drug Inc:
Data Sources and Methodology
This transparency report for Fight The New Drug Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.